Home » Topics » BioWorld Science

BioWorld Science
RSS

Merck & Co. identifies nicotinic alpha7 receptor PAMs

June 3, 2021

Crinetics Pharmaceuticals synthesizes new melanocortin MC2 receptor antagonists

June 3, 2021

Nurix Therapeutics presents new PROTACs

June 3, 2021

Lophora ApS patents 5-HT2A receptor agonists

June 3, 2021

Wave Life Sciences presents promising preclinical data for its ADAR editing program

June 3, 2021

First patient enrolled in phase Ib study of LB-100 for treatment of small cell lung cancer

June 3, 2021

Centivax enters strategic partnership with NMRC for phase I development of Centi-B9

June 3, 2021

Encouraging development updates for SupraAntigen-derived liposomal AD vaccine candidates

June 3, 2021

ATTR removal observed in vitro and in vivo with NI-006

June 3, 2021

ADO-09 shown to be superior to insulin aspart in type 1 diabetes patients

June 3, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 16, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 16, 2025.
CTAD 2025: Diagnosing semaglutide’s failure in Alzheimer’s trials
BioWorld
A little over a week after announcing that the Evoke and Evoke+ studies failed to show that oral semaglutide could slow cognition decline in patients with...
Hits’ Hyperlab launches as ‘virtual AI lab’ for new drug discovery
BioWorld Science
Things once done in laboratories can now be done with computers and AI, said Kim Woo-youn, CEO and cofounder of Hits Inc. “We live in the age of ‘digital...
ADEL wins $1.04B Sanofi deal for tau-targeting Alzheimer’s drug
BioWorld
ADEL Inc. closed a year-end licensing deal worth up to $1.04 billion with Sanofi SA for ADEL-Y01, a specific tau-targeting Alzheimer’s disease drug candidate in a...